UBS Group »

Verrica Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $178k 24k 7.32
2023-09-30 $43k 11k 3.88
2023-06-30 $75k 13k 5.77
2023-03-31 $11k 1.8k 6.50
2022-12-31 $5.3k 1.9k 2.75
2022-09-30 $17k 5.5k 3.02
2022-06-30 $6.5k 3.4k 1.90
2022-03-31 $23k 2.8k 8.19
2021-12-31 $40k 4.4k 9.25
2021-09-30 $49k 3.8k 12.60
2021-06-30 $84k 7.6k 11.01
2021-03-31 $150k 9.9k 15.10
2020-12-31 $72k 6.1k 11.74
2020-09-30 $24k 3.1k 7.50
2020-06-30 $81k 7.3k 11.00
2020-03-31 $120k 11k 10.91
2019-12-31 $299k 19k 16.00
2019-09-30 $205k 14k 14.72
2019-06-30 $50k 4.4k 11.50
2019-03-31 $28k 2.2k 13.16
2018-12-31 $33k 4.2k 8.00
2018-09-30 $54k 3.4k 15.95
2018-06-30 $2.0k 107 18.69